Raymond James initiated coverage on Black Diamond Therapeutics with a new price target

7/31/24 6:19:23 AM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

Raymond James initiated coverage of Black Diamond Therapeutics with a rating of Outperform and set a new price target of $20.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$BDTX

Date	Price Target	Rating	Analyst
7/31/2024	$20.00	Outperform	Raymond James
7/14/2023		Overweight	Piper Sandler
6/30/2023	$2.00 → $10.00	Hold → Buy	Stifel
6/28/2023	$11.00	Neutral → Buy	H.C. Wainwright
6/27/2023	$10.00	Neutral → Outperform	Wedbush
3/29/2022		Outperform → Neutral	Wedbush
3/22/2022		Buy → Neutral	H.C. Wainwright
9/30/2021	$10.00	Hold	Stifel